Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 9/2022

09-06-2022 | Insomnia | Original Article

Cross-cultural adaptation, validation, and the reliability of the Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis

Authors: Fatih Özden, Mehmet Özkeskin, Nur Yüceyar

Published in: Neurological Sciences | Issue 9/2022

Login to get access

Abstract

Purpose

Examining sleep-related behavioral disorder strategies in detail for MS patients provides an essential assessment to address specific disease findings. The aim of the study was to demonstrate the reliability and validity of the Turkish Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis (MS).

Methods

A total of 100 MS patients were filled Sleep-Related Behaviors Questionnaire (SRBQ), Beck Depression Inventory (BDI), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). One week later, 30 randomly selected patients were refilled the SRBQ. The test–retest reliability, internal consistency, and contruct validity were determined.

Results

The mean age of the individuals included in the study was 38.9 ± 11.0 years. The ICC value of the reproducibility of SRBQ was calculated as 0.877 (CI: 0.74–0.94). The test–retest reliability of the SRBQ was excellent (ICC > 0.80). Cronbach’s alpha value of the SRBQ was 0.877, which indicates excellent consistency. The SRBQ had correlation coefficients of 0.573, 0.509, and 0.523 with ISI, PSQI, and BDI, respectively. The SRBQ had high validity (r > 0.50, p < 0.01).

Conclusion

The Turkish SRBQ was found to be valid and reliable in patients with MS. Owing to the long but comprehensive nature of the SRBQ, a low-cost detailed measurement could be obtained in clinical practice.
Literature
1.
Pokryszko-Dragan A, Bilińska M, Gruszka E, Biel Ł, Kamińska K, Konieczna K (2013) Sleep disturbances in patients with multiple sclerosis. Neurol Sci 34(8):1291–1296CrossRef
2.
Bamer A, Johnson K, Amtmann D, Kraft G (2008) Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler J 14(8):1127–1130CrossRef
3.
Merlino G, Fratticci L, Lenchig C, Valente M, Cargnelutti D, Picello M, Serafini A, Dolso P, Gigli G (2009) Prevalence of ‘poor sleep’among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med 10(1):26–34CrossRef
4.
Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr K-M, Bø L (2012) Poor sleep in patients with multiple sclerosis. PLoS ONE 7(11):e49996CrossRef
5.
Garland SN, Scurrey SR, Ploughman M (2017) Factors associated with poor sleep in older adults with multiple sclerosis. Int J Behav Med 24(6):937–945CrossRef
6.
Fleming WE, Pollak CP (2005) Sleep disorders in multiple sclerosis. In: Seminars in neurology. Copyright© 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New 01. pp 64–68
7.
Sakkas GK, Giannaki CD, Karatzaferi C, Manconi M (2019) Sleep abnormalities in multiple sclerosis. Curr Treat Options Neurol 21(1):4CrossRef
8.
Taphoorn M, Van Someren E, Snoek F, Strijers R, Swaab D, Visscher F, De Waal L, Polman C (1993) Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol 240(7):446–448CrossRef
9.
Irwin MR, Wang M, Ribeiro D, Cho HJ, Olmstead R, Breen EC, Martinez-Maza O, Cole S (2008) Sleep loss activates cellular inflammatory signaling. Biol Psychiat 64(6):538–540CrossRef
10.
Melamud L, Golan D, Luboshitzky R, Lavi I, Miller A (2012) Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. J Neurol Sci 314(1–2):37–40CrossRef
11.
Kaminska M, Kimoff R, Schwartzman K, Trojan D (2011) Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction. J Neurol Sci 302(1–2):7–13CrossRef
12.
Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4(5):487–504CrossRef
13.
Hughes AJ, Dunn KM, Chaffee T (2018) Sleep disturbance and cognitive dysfunction in multiple sclerosis: a systematic review. Curr Neurol Neurosci Rep 18(1):1–9CrossRef
14.
Amtmann D, Bamer AM, Kim J, Chung H, Salem R (2018) People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures. Disabil Health J 11(1):99–107CrossRef
15.
Riachi N, Ahdab R, Challah MA, Creange A, Lefaucheur J-P, Ayache SS (2015) Fatigue in multiple sclerosis
16.
Braley TJ, Boudreau EA (2016) Sleep disorders in multiple sclerosis. Curr Neurol Neurosci Rep 16(5):50CrossRef
17.
Ree MJ, Harvey AG (2004) Investigating safety behaviours in insomnia: the development of the Sleep-Related Behaviours Questionnaire (SRBQ). Behav Chang 21(1):26–36CrossRef
18.
Lebrun C, Gély-Nargeot M-C, Maudarbocus KH, Bayard S (2018) Assessing sleep-related safety behaviors: adaptation and validation of a french version of the sleep-related behaviors questionnaire in a nonclinical sample. Behav Sleep Med
19.
Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191CrossRef
20.
Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46(12):1417–1432CrossRef
21.
Faul F, Erdfelder E, Buchner A, Lang A-G (2009) Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behavior research methods 41 (4):1149–1160
22.
Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191CrossRef
23.
Walter S, Eliasziw M, Donner A (1998) Sample size and optimal designs for reliability studies. Stat Med 17(1):101–110CrossRef
24.
Bonett DG (2002) Sample size requirements for estimating intraclass correlations with desired precision. Stat Med 21(9):1331–1335CrossRef
25.
Hisli N (1989) The validity and reliability of Beck Depression Inventory for university students. Psikoloji dergisi 7:3–13
26.
Boysan M, Gulec M, Besiroglu L, Kalafat T (2010) Psychometric properties of the Insomnia Severity Index in Turkish sample
27.
Ağargün MY, Kara H, Anlar Ö (1996) The validity and reliability of the Pittsburgh Sleep Quality Index. Turk Psikiyatri Derg 7(2):107–115
28.
Juniper EF (1996) How to develop and validate a new health-related quality of life instrument. Quality of life and pharamacoeconomics in clinical trials:49–56
29.
Baumgartner TA, Chung H (2001) Confidence limits for intraclass reliability coefficients. Meas Phys Educ Exerc Sci 5(3):179–188CrossRef
30.
Portney LG, Watkins MP (2009) Foundations of clinical research: applications to practice, vol 892. Pearson/Prentice Hall Upper Saddle River, NJ
31.
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42CrossRef
32.
Hamilton N, Freche R, Zhang Y, Zeller G, Carroll I (2021) Test anxiety and poor sleep: a vicious cycle. Int J Behav Med 28(2):250–258CrossRef
33.
Regier DA, Kuhl EA, Kupfer DJ (2013) The DSM-5: classification and criteria changes. World Psychiatry 12(2):92–98CrossRef
Metadata
Title
Cross-cultural adaptation, validation, and the reliability of the Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis
Authors
Fatih Özden
Mehmet Özkeskin
Nur Yüceyar
Publication date
09-06-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06196-4

Other articles of this Issue 9/2022

Neurological Sciences 9/2022 Go to the issue

COVID-19

COVID-19 infection and Down syndrome—challenges and future directions for care in children

Brief Communication

Thyroid dysfunction in Portuguese amyotrophic lateral sclerosis patients

Original Article

Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center

Original Article

Tuberculous myelitis: a prospective follow-up study

Letter to the Editor

Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

Original Article

Recurrent glioblastoma: which treatment? A real-world study from the Neuro-oncology Unit “Regina Elena” National Cancer Institute